D. McKillop

820 total citations
24 papers, 676 citations indexed

About

D. McKillop is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, D. McKillop has authored 24 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in D. McKillop's work include Pharmacogenetics and Drug Metabolism (11 papers), HER2/EGFR in Cancer Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). D. McKillop is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), HER2/EGFR in Cancer Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). D. McKillop collaborates with scholars based in United Kingdom, Canada and United States. D. McKillop's co-authors include Michael G. Hutchison, P. J. Phillips, Alex McCormick, Martin Wild, Nick Bushby, E. A. Partridge, Helen Swaisland, William J. Herron, I. D. Cockshott and R. A. Yates and has published in prestigious journals such as Journal of Clinical Oncology, Biochemistry and Biochemical Journal.

In The Last Decade

D. McKillop

24 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. McKillop United Kingdom 13 302 257 248 174 74 24 676
Punit H. Marathe United States 15 220 0.7× 50 0.2× 246 1.0× 158 0.9× 51 0.7× 31 854
Lina Yin China 21 146 0.5× 143 0.6× 310 1.3× 204 1.2× 234 3.2× 37 1.0k
Tsu‐Han Lin United States 13 130 0.4× 103 0.4× 149 0.6× 75 0.4× 121 1.6× 20 751
Hans Stieltjes Belgium 17 154 0.5× 132 0.5× 169 0.7× 64 0.4× 247 3.3× 26 628
Margaret Kindlen United States 8 269 0.9× 92 0.4× 478 1.9× 117 0.7× 10 0.1× 11 842
John Kemp United Kingdom 14 189 0.6× 96 0.4× 109 0.4× 113 0.6× 46 0.6× 23 652
Stephen T. Ingalls United States 22 172 0.6× 85 0.3× 657 2.6× 34 0.2× 28 0.4× 42 1.1k
Mohammed Ullah United States 17 378 1.3× 76 0.3× 253 1.0× 196 1.1× 22 0.3× 24 807
Tsutomu Yoshimura Japan 13 183 0.6× 31 0.1× 205 0.8× 171 1.0× 32 0.4× 28 594

Countries citing papers authored by D. McKillop

Since Specialization
Citations

This map shows the geographic impact of D. McKillop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. McKillop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. McKillop more than expected).

Fields of papers citing papers by D. McKillop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. McKillop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. McKillop. The network helps show where D. McKillop may publish in the future.

Co-authorship network of co-authors of D. McKillop

This figure shows the co-authorship network connecting the top 25 collaborators of D. McKillop. A scholar is included among the top collaborators of D. McKillop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. McKillop. D. McKillop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCormick, Alex, Eva M. Lenz, P. J. Phillips, et al.. (2007). In vitrometabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes. Xenobiotica. 37(9). 972–985. 4 indexed citations
2.
3.
McKillop, D., et al.. (2005). Cytochrome P450-dependent metabolism of gefitinib. Xenobiotica. 35(1). 39–50. 114 indexed citations
4.
McKillop, D., Michael G. Hutchison, E. A. Partridge, et al.. (2004). Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man. Xenobiotica. 34(10). 917–934. 115 indexed citations
5.
McKillop, D., Alex McCormick, P. J. Phillips, et al.. (2004). In vitrometabolism of gefitinib in human liver microsomes. Xenobiotica. 34(11-12). 983–1000. 54 indexed citations
6.
McKillop, D., et al.. (2004). Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog. Xenobiotica. 34(10). 901–915. 40 indexed citations
7.
McKillop, D., et al.. (2004). 660 Fulvestrant does not markedly inhibit human cytochrome p450 isozymes: results from in vitro studies. European Journal of Cancer Supplements. 2(8). 199–199. 2 indexed citations
8.
McKillop, D., Holger Eidtmann, A. Riva, et al.. (2004). Intratumoral and plasma concentrations of gefitinib in breast cancer patients: Preliminary results from a presurgical investigatory study (BCIRG 103). Journal of Clinical Oncology. 22(14_suppl). 581–581. 11 indexed citations
9.
Wild, Martin, et al.. (1999). Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. Xenobiotica. 29(8). 847–857. 42 indexed citations
10.
McKillop, D., D J Back, Alex McCormick, James A. Evans, & J. Tjia. (1999). Preclinical andin vitroassessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions. Xenobiotica. 29(4). 395–408. 5 indexed citations
11.
Boobis, Alan R., et al.. (1998). Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samples. Xenobiotica. 28(5). 493–506. 21 indexed citations
12.
McKillop, D., et al.. (1998). Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica. 28(9). 845–853. 40 indexed citations
13.
Poucher, Simon M., et al.. (1996). Pharmacodynamics of ZM 241385, a Potent A2a Adenosine Receptor Antagonist, after Enteric Administration in Rat, Cat and Dog. Journal of Pharmacy and Pharmacology. 48(6). 601–606. 39 indexed citations
14.
McKillop, D., Peter J. Simons, I. D. Cockshott, et al.. (1995). Enantioselective metabolism and pharmacokinetics of Casodex in the male rat. Xenobiotica. 25(6). 623–633. 9 indexed citations
15.
McKillop, D., et al.. (1993). Metabolism of Casodex in laboratory animals. Xenobiotica. 23(7). 781–798. 29 indexed citations
16.
McKillop, D., et al.. (1993). Metabolism and enantioselective pharmacokinetics of Casodex in man. Xenobiotica. 23(11). 1241–1253. 47 indexed citations
17.
Johnson, Stephen B., D. McKillop, James B. Miller, & Ivan K. Smith. (1993). The Effects on Rat Thyroid Function of an Hepatic Microsomal Enzyme Inducer. Human & Experimental Toxicology. 12(2). 153–158. 20 indexed citations
18.
McKillop, D., et al.. (1990). The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboon. Xenobiotica. 20(4). 401–415. 3 indexed citations
19.
McLean, Paul A., David A. Wink, Stephen K. Chapman, et al.. (1989). A new method for extraction of iron-molybdenum cofactor (FeMoco) from nitrogenase adsorbed to DEAE-cellulose. 1. Effects of anions, cations, and preextraction treatments. Biochemistry. 28(24). 9402–9406. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026